Engineers Gate Manager’s Hemab Therapeutics COAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$205K Buy
+6,655
New +$292K ﹤0.01% 1974

Other funds holding COAG

Engineers Gate Manager's COAG Position: Q3 2026 in Review

Engineers Gate Manager opened a new position in Hemab Therapeutics (COAG) in Q3 2026: 6,655 shares worth $205K. The stake represents ﹤0.01% of the portfolio and ranks #1974 among its holdings.

89 funds tracked by Wall St. Rank hold COAG as of Q3 2026.

  • Engineers Gate Manager held 6,655 shares of Hemab Therapeutics worth $205K as of Q3 2026.
  • Hemab Therapeutics was a new Engineers Gate Manager position in Q3 2026.
  • Hemab Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q3 2026, its #1974 holding.
  • 89 funds tracked by Wall St. Rank held Hemab Therapeutics as of Q3 2026.

Based on Engineers Gate Manager's 13F filing for Q3 2026, filed 16 Nov 2026.